Back to search

Article

Serglycin-Mediated Selective Reactivation of the Novel YAP/CRISPLD2 Developmental Axis Promotes Metastasis and Sorafenib Resistance in Hepatocellular Carcinoma

2020-12-29

Abstract excerpt

<h4>Background: </h4> The extracellular matrix (ECM) component serglycin promotes the epithelial-to-mesenchymal transition (EMT) and metastasis in an autocrine manner. However, the detailed mechanism underlying the roles of serglycin in Hepatocellular carcinoma (HCC) metastasis progression remains to be clarified. <h4>Methods: </h4> Analyzing 123 patients’ serum by ELISA to investigate the association between serg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf67d4cb-f710-563f-9a22-7907495f120a
DOI
10.21203/rs.3.rs-135613/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serglycin-Mediated Selective Reactivation of the Novel YAP/CRISPLD2 Developmental Axis Promotes Metastasis and Sorafenib Resistance in Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-135613/v1
Select a neighboring publication to make it the new centre.